glp 1 effects on heart The Cardiovascular Biology of Glucagon-like Peptide-1: Cell Metabolism Effects of Glucagon-Like Peptide 1

What are glucagon-like peptide-1 (GLP-1) receptor agonists?Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 drugs, are a class of peptide medications (not dietary supplements) primarily used to treat type 2 diabetes (T2D) and obesity

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers wrote in a new study.

Mounjaro (tirzepatide) and Ozempic (semaglutide) are often praised on social media for helping people lose weight

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication

The combination therapy of GLP-1 receptor agonists and metformin demonstrates superior safety over monotherapy, while revealing novel adverse events and demographic-specific risk patterns, thereby offering reliable evidence to inform clinical practice.

Yes, in certain situations